HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 384 filers reported holding HALOZYME THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.39 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $3,313,453 | +103704.9% | 86,740 | +38.7% | 0.02% | -32.0% |
Q4 2022 | $3,192 | -99.9% | 62,557 | -3.0% | 0.02% | 0.0% |
Q3 2022 | $3,005,000 | -5.0% | 64,525 | +2.1% | 0.02% | -3.8% |
Q2 2022 | $3,164,000 | +12.8% | 63,192 | -2.5% | 0.03% | +30.0% |
Q1 2022 | $2,806,000 | -3.9% | 64,802 | -25.6% | 0.02% | -4.8% |
Q4 2021 | $2,921,000 | -15.7% | 87,123 | -2.3% | 0.02% | 0.0% |
Q3 2021 | $3,464,000 | -10.1% | 89,133 | -11.1% | 0.02% | -8.7% |
Q2 2021 | $3,855,000 | -25.2% | 100,222 | -1.9% | 0.02% | -25.8% |
Q1 2021 | $5,157,000 | -0.6% | 102,204 | -2.5% | 0.03% | -6.1% |
Q4 2020 | $5,187,000 | +357.8% | 104,798 | +187.7% | 0.03% | +312.5% |
Q3 2020 | $1,133,000 | -0.7% | 36,423 | -11.2% | 0.01% | -11.1% |
Q2 2020 | $1,141,000 | +20.0% | 41,034 | +1.0% | 0.01% | 0.0% |
Q1 2020 | $951,000 | – | 40,615 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Third Security, LLC | 19,305,403 | $233,209,000 | 10.86% |
BB BIOTECH AG | 7,379,832 | $89,148,000 | 3.13% |
SENZAR ASSET MANAGEMENT, LLC | 550,544 | $6,650,572,000 | 1.72% |
SNYDER CAPITAL MANAGEMENT L P | 2,232,114 | $26,964,000 | 1.69% |
Sterling Global Strategies LLC | 22,000 | $266,000 | 0.98% |
IRIDIAN ASSET MANAGEMENT LLC/CT | 9,290,024 | $112,223,000 | 0.98% |
MSD Partners, L.P. | 965,000 | $11,657,000 | 0.94% |
DOHENY ASSET MANAGEMENT /CA | 130,950 | $1,582,000 | 0.81% |
Taylor Wealth Management Partners | 128,110 | $1,548,000 | 0.69% |
Bellevue Group AG | 318,000 | $3,841,000 | 0.69% |